Skip to main content
. Author manuscript; available in PMC: 2023 Oct 16.
Published in final edited form as: Acc Mater Res. 2022 Jan 12;3(2):134–148. doi: 10.1021/accountsmr.1c00177

Table 1:

Bio-conjugated nanomaterials for the diagnosis of SARS-CoV-2 antigen or virus

Target molecules Detection platform Bio-conjugated Nanostructure used Detection time Detection Sensitivity References
SARS-CoV-2 N gene Colorimetric RNA/DNA attached gold nanoparticle 10 minutes .18 ng/μL 16
SARS-CoV-2 spike protein Colorimetric Antibody-conjugated gold nanoparticles 5 minutes 1 ng/mL 23
SARS-CoV-2 spike protein Colorimetric MNAzyme - conjugated gold nanoparticles 5 minutes 90% for clinical samples 39
SARS-CoV-2 S, N & P gene Colorimetric Antibody-conjugated gold nanoparticles 20 minutes 95% for clinical samples 21
SARS-CoV-2 IgM/IgG antibodies Colorimetric based Lateral Flow Nucleoprotein attached gold nanoparticles 15 minutes 93% for clinical samples 27
SARS-CoV-2 RNA Colorimetric CRISPR/Cas RNA/DNA attached gold nanoparticle 15 minutes 95.2% for clinical samples 22
SARS-CoV-2 spike protein SERS Antibody-conjugated gold nanoparticles 10 minutes 4 pg/mL 23
SARS-CoV-2 spike protein SERS Antibody attached graphene 15 minutes 3.75 fg/mL 38
SARS-CoV-2 IgM/IgG antibodies SERS based LFA Antigen attached SiO2@Ag nanoparticle 20 minutes 100% for clinical samples 35
SARS-CoV-2 spike protein SERS Antibody-conjugated gold nanoparticles 20 minutes 87.7% clinical sample 42
SARS-CoV-2 spike protein NSET Aptamer-conjugated gold nanoparticles 10 minutes 130 fg/mL 24
SARS-CoV-2 spike protein Fluorescence ACE2 attached SWCNT 90 minutes 12.6 nM 37
SARS-CoV-2 IgG and IgM Fluorescence based LFA Antigen/SiO2@Au@QD nanobeads 15 minutes 100% for clinical samples 28
SARS-CoV-2 spike protein NSET Antibody coated quantum dots 20 minutes 200 fg/mL 30
SARS-CoV-2 spike protein Field effect transistor Antibody coated MXene-graphene 50 seconds 1 fg/mL 36
SARS-CoV-2 RNA RT-PCR 6 hours 97% for clinical samples 8
SARS-CoV-2 RNA CRISPR-Cas 40 minutes 95% for clinical samples 11
SARS-CoV-2 antigen LFA 15 minutes 95% for clinical samples 8